Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.23
-0.46 (-5.29%)
Nov 18, 2026, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $239.98 million as of November 18, 2026. It is the 18,827th most valuable company in the world and the 3,303rd biggest in the United States. Its market cap has decreased by 12.45% in one year.
Market Cap
239.98M
Enterprise Value
223.12M
1-Year Change
-12.45%
Global Rank
Country Rank
#3,303 United States
Category
ChartMarket Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has decreased from $289.30M to $239.98M, a decrease of -17.05%. That is a compound annual growth rate of -1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 239.98M | -47.28% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 250.82M |
| Century Therapeutics | 250.60M |
| Clinuvel Pharmaceuticals | 246.77M |
| Lexeo Therapeutics | 244.22M |
| Allogene Therapeutics | 241.11M |
| Rocket Pharmaceuticals | 235.60M |
| Keros Therapeutics | 235.49M |
| Arcturus Therapeutics Holdings | 231.73M |